Last Price
110.18
Today's Change
-1.90 (1.69%)
Day's Change
109.82 - 112.08
Trading Volume
9,359,259
Market Cap
279 Billion
Shares Outstanding
2 Billion
Avg Volume
9,306,377
Avg Price (50 Days)
116.14
Avg Price (200 Days)
122.67
PE Ratio
20.40
EPS
5.40
Earnings Announcement
31-Oct-2024
Previous Close
112.08
Open
111.82
Day's Range
109.825 - 112.0787
Year Range
99.14 - 134.63
Trading Volume
7,811,316
1 Day Change
-1.70%
5 Day Change
-2.64%
1 Month Change
-5.49%
3 Month Change
-12.45%
6 Month Change
-15.18%
Ytd Change
-2.70%
1 Year Change
8.26%
3 Year Change
32.59%
5 Year Change
39.66%
10 Year Change
92.89%
Max Change
27767.57%
No result.
Sector: Healthcare - Healthcare
Industry: Drug Manufacturers—General
Description:
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.